Fundraising Fox

Rob Hopfner

Investor

Managing Partner at Pivotal bioVenture Partners · RPh, PhD, MBA at Pivotal Life Sciences

San Francisco, California, United States

About

Rob Hopfner joined Pivotal Life Sciences in 2017 and has experience across venture investing stages, from early/seed company building to later-stage private and public investing in the life sciences. He was previously a Managing Director at Bay City Capital and earlier worked in DuPont/Merck Pharmaceuticals' Business Development & Strategy group. He holds an RPh in Pharmacy and a PhD in Pharmacology from the University of Saskatchewan, an MBA from the University of Chicago Booth School of Business, and completed post-doctoral work at Harvard Medical School.

Invests in

BiotechHealthtechMedical Devices

Experience

  1. Pivotal bioVenture PartnersManaging Partnercurrent2017 — presentSan Francisco
  2. Pivotal bioVenture PartnersExecutive Committeecurrent2022 — presentSan Francisco, California, United States
  3. LAND TherapeuticsBoardcurrent2024 — presentBoston, Massachusetts, United States
  4. EvommuneBoardcurrent2020 — presentPalo Alto, California, United States
  5. PlexiumBoardcurrent2021 — presentSan Diego, California, United States
  6. Inozyme PharmaBoard2019 — 2025Boston, Massachusetts, United States
  7. OculisBoard2017 — 2023Lausanne, Vaud, Switzerland
  8. VaxcyteBoard2017 — 2021Foster City, California, United States
  9. Bay City Capital LLCManaging Director and Partner2009 — 2017San Francisco, CA
  10. Bay City Capital LLCPrincipal2006 — 2009San Francisco, CA
  11. Vtesse, Inc.Board2015 — 2017
  12. Civitas TherapeuticsBoard2013 — 2014Boston, Massachusetts, United States
  13. Dermira, Inc.Board2010 — 2014Palo Alto, California, United States
  14. Aciex Therapeutics, Inc.Board2007 — 2014Andover, Massachusetts, United States
  15. Hyperion TherapeuticsBoard2009 — 2013South San Francisco, California, United States
  16. PTC Therapeutics, Inc.Board2005 — 2013Warren, New Jersey, United States
  17. NextWave TherapeuticsBoard2010 — 2012Palo Alto, California, United States

Education

  1. The University of Chicago Booth School of BusinessMBA, Finance
  2. Harvard Medical SchoolPost doctoral fellowship
  3. University of SaskatchewanDoctor of Philosophy (Ph.D.), Pharmacology
  4. University of SaskatchewanBachelor of Science (B.Sc.), Pharmacy

Skills & more

Venture Capital21Corporate Development10Due Diligence10Start-ups5Biotechnology8Technology Transfer2Healthcare3Drug Discovery1Lifesciences3Investments2Private Equity2Commercialization2
+6 moreEntrepreneurshipBusiness PlanningStrategic PartnershipsLife SciencesStrategyPharmaceutical Industry

From Rob's professional profile.

Same school

Shared employers

Deals · 2

PlexiumBoard seat

via Pivotal bioVenture Partners · filed Aug 2025 · $60.1M raise

SutroVaxBoard seat

via Pivotal bioVenture Partners · filed Apr 2020 · $110M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Pivotal bioVenture Partners